Adalimumab vs Teplizumab

## Adalimumab vs Teplizumab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Teplizumab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Teplizumab — N/A.

## Chemical Properties

**Type**: Adalimumab — Antibody; Teplizumab — Antibody.